TITLE

Cost-utility analysis of genetic testing in neonatal diabetes

PUB. DATE
September 2011
SOURCE
Diabetes Digest;2011, Vol. 10 Issue 3, p141
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses a cost-utility analysis by S. A. Greeley and colleagues on routine genetic screening in children with permanent neonatal diabetes (ND).
ACCESSION #
84602762

 

Related Articles

  • Economic impact of a genetic test for cisplatin-induced ototoxicity. Dionne, F; Mitton, C; Rassekh, R; Brooks, B; Ross, C; Hayden, M; Carleton, B // Pharmacogenomics Journal;Aug2012, Vol. 12 Issue 4, p359 

    No abstract available.

  • Defining and managing incidental findings in genetic and genomic practice. Shkedi-Rafid, Shiri; Dheensa, Sandi; Crawford, Gillian; Fenwick, Angela; Lucassen, Anneke // Journal of Medical Genetics;Nov2014, Vol. 51 Issue 11, p715 

    The rapidly declining costs and increasing speeds of whole-genome analysis mean that genetic testing is undergoing a shift from targeted approaches to broader ones that look at the entire genome. As whole-genome technologies gain widespread use, questions about the management of so-called...

  • Refitting of the UKPDS 68 Risk Equations to Contemporary Routine Clinical Practice Data in the UK. McEwan, P.; Bennett, H.; Ward, T.; Bergenheim, K. // PharmacoEconomics;Feb2015, Vol. 33 Issue 2, p149 

    Objective: Economic evaluations of new diabetes therapies rely heavily upon the UK Prospective Diabetes Study (UKPDS) equations for prediction of cardiovascular events; however, concerns persist regarding their relevance to current clinical practice and appropriate use in populations other than...

  • Costs of deep foot infections in patients with diabetes mellitus. Tennvall, G.R.; Apelqvist, J.; Eneroth, M. // PharmacoEconomics;2000, Vol. 18 Issue 3, p225 

    Objective: To calculate costs for the management of deep foot infections and to identify the most important factors related to treatment costs.Design: Costs for in-hospital care, surgery, investigations, antibacterials, visits to the foot-care team, orthopaedic...

  • Road transport externalities Proost, Stef; Calthrop, Edward // Environmental & Resource Economics;Apr/Jun1998, Vol. 11 Issue 3/4, p335 

    During the last decade much progress has been made in defining & measuring the external costs of transport. As the cost of tolling equipment falls, the set of realistic policy options to internalise these externalities will continue to grow. This will determine the research and policy agenda. We...

  • Genetic testing cost effective in diabetes.  // PharmacoEconomics & Outcomes News;7/7/2012, Issue 657, p6 

    The article discusses research on the cost effectiveness of maturity-onset diabetes of the young (MODY) genetic testing, referencing a study by R. N. Naylor presented at the 72nd Annual Scientific Sessions of the American Diabetes Association.

  • Genetic testing for MODY appears cost-effective for select populations. Adams, Stacey; Costa, Samantha; Foster, Melissa; Todak, Alexandria // Endocrine Today;Oct2013, Vol. 11 Issue 10, p45 

    The article discusses the results of a study which showed the cost effectiveness of personalized genetic testing for treating patients with maturity-onset diabetes of the young (MODY), referencing a research by Rochelle N. Naylor and colleagues, published in the journal "Diabetes Care."

  • GENETIC TESTING FOR INTELLECTUAL DISABILITY. Habela, Christa W.; Hamosh, Ada // Contemporary Pediatrics;Jun2013, Vol. 30 Issue 6, p21 

    The article discusses the genetic testing for intellectual disability (ID) or global developmental delay (GDD). It is mentioned that ID limits the intellectual functioning and adaptive behavior before the age of 18. It states that most of the study results, history and physical examination are...

  • Are you confident your patients have the correct diagnosis? Shepherd, Maggie // Journal of Diabetes Nursing;2012, Vol. 16 Issue 10, p403 

    Misdiagnosis of monogenic diabetes is common and can lead to years of unnecessary insulin treatment. Aids to diagnosis are available and can differentiate between maturity onset diabetes of the young and type 1 diabetes; however, these are seldom used routinely in clinical practice. This article...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics